However, in patients with T2DM, insulin signal transduction pathways are inhibited, resulting in reduced activity of the PI3K/Akt signaling pathway, thereby affecting the osteogenic differentiation ability of BMSCs (4). Here, INS is linked to type 2 diabetes mellitus.